Powl Brian T. Insider Trades

Insider Trading History

Track insider trading activity for Powl Brian T.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kura Oncology
Kura Oncology KURA
Chief Commercial Officer
Holding Value $1.8M 173,614 shares
Last Trade
May 21, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$110k 10,000 shares
$11.00
$10.38
Kura Oncology
Kura Oncology KURA
Chief Commercial Officer
Holding Value $1.91M 183,614 shares
Last Trade
May 19, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.12k 339 shares
$9.21
$10.38
Kura Oncology
Kura Oncology KURA
Chief Commercial Officer
Holding Value $1.92M 184,847 shares
Last Trade
Jan 27, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$54.3k 6,414 shares
$8.46
$10.38
Kura Oncology
Kura Oncology KURA
Chief Commercial Officer
Holding Value $1.97M 189,689 shares
Last Trade
Jan 02, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.55M 150,000 shares
$10.34
$10.38
Kura Oncology
Kura Oncology KURA
Chief Commercial Officer
Holding Value $1.45M 139,689 shares
Last Trade
Nov 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$99.4k 8,887 shares
$11.18
$10.38
Kura Oncology
Kura Oncology KURA
Chief Commercial Officer
Holding Value $1.54M 148,576 shares
Last Trade
Nov 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$522k 48,900 shares
$10.68
$10.38
Kura Oncology
Kura Oncology KURA
Chief Commercial Officer
Holding Value $1.03M 99,676 shares
Last Trade
Sep 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$79.5k 8,891 shares
$8.94
$10.38
Kura Oncology
Kura Oncology KURA
Chief Commercial Officer
Holding Value $1.13M 108,567 shares
Last Trade
Sep 27, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$443k 48,900 shares
$9.05
$10.38
Kura Oncology
Kura Oncology KURA
Chief Commercial Officer
Holding Value $619k 59,667 shares
Last Trade
Jan 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$12.5k 1,583 shares
$7.87
$10.38
Kura Oncology
Kura Oncology KURA
Chief Commercial Officer
Holding Value $960k 92,500 shares
Last Trade
Jan 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.2M 138,750 shares
$8.68
$10.38
Kura Oncology
Kura Oncology KURA
Chief Commercial Officer
Holding Value $311k 30,000 shares
Last Trade
Jan 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$461k 30,000 shares
$15.36
$10.38
Kura Oncology
Kura Oncology KURA
Chief Commercial Officer
Holding Value $2.08M 200,000 shares
Last Trade
Aug 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.34M 200,000 shares
$11.72
$10.38
Fate Therapeutics
Fate Therapeutics FATE
Chief Commercial Officer
Holding Value $88.9k 41,146 shares
Last Trade
Jul 05, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$18.8k 3,854 shares
$4.87
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Chief Commercial Officer
Holding Value $918k 425,000 shares
Last Trade
Feb 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.88M 425,000 shares
$6.77
$2.16
Fate Therapeutics
Fate Therapeutics FATE
Chief Commercial Officer
Holding Value $97.2k 45,000 shares
Last Trade
Jun 27, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.18M 45,000 shares
$26.25
$2.16

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up